KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash & Current Investments (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Cash & Current Investments for 17 consecutive years, with $10.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 1.71% to $10.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.7 billion, a 1.71% decrease, with the full-year FY2025 number at $10.7 billion, down 1.71% from a year prior.
  • Cash & Current Investments was $10.7 billion for Q4 2025 at Bristol Myers Squibb, down from $15.7 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $17.0 billion in Q4 2021 to a low of $6.3 billion in Q2 2024.
  • A 5-year average of $11.3 billion and a median of $10.9 billion in 2024 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: plummeted 50.62% in 2022, then skyrocketed 116.16% in 2025.
  • Bristol Myers Squibb's Cash & Current Investments stood at $17.0 billion in 2021, then plummeted by 45.46% to $9.3 billion in 2022, then soared by 32.71% to $12.3 billion in 2023, then dropped by 11.57% to $10.9 billion in 2024, then fell by 1.71% to $10.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Cash & Current Investments are $10.7 billion (Q4 2025), $15.7 billion (Q3 2025), and $13.6 billion (Q2 2025).